| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041748879 |
| P356 | DOI | 10.1038/BMT.2008.270 |
| P698 | PubMed publication ID | 18762766 |
| P5875 | ResearchGate publication ID | 23229031 |
| P2093 | author name string | J P Donnelly | |
| T Feuth | |||
| N M A Blijlevens | |||
| W J F M van der Velden | |||
| P2860 | cites work | Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation | Q79370344 |
| Palifermin for oral mucositis after intensive therapy for hematologic cancers | Q28298574 | ||
| Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview | Q33952985 | ||
| Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis | Q34571309 | ||
| Impaired gut function as risk factor for invasive candidiasis in neutropenic patients | Q34612183 | ||
| Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients | Q35755733 | ||
| Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? | Q35761565 | ||
| A scoring system for the assessment of oral mucositis in daily nursing practice | Q36553808 | ||
| New directions in the genomics of allogeneic hematopoietic stem cell transplantation | Q36714821 | ||
| A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation. | Q40451325 | ||
| Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients | Q40502316 | ||
| Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy | Q40551177 | ||
| Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. | Q40573634 | ||
| Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis | Q40585149 | ||
| Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. | Q40629698 | ||
| Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group | Q40700791 | ||
| Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease | Q44429781 | ||
| Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy | Q44915687 | ||
| Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. | Q54030467 | ||
| Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia | Q55061788 | ||
| From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel | Q68497120 | ||
| The economic burden of supportive care of cancer patients | Q75438015 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 55-60 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Febrile mucositis in haematopoietic SCT recipients | |
| P478 | volume | 43 |
| Q35583396 | 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation |
| Q40734670 | Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study |
| Q44160397 | Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT. |
| Q37818225 | Evaluation of current and upcoming therapies in oral mucositis prevention |
| Q38202568 | Host impairments in patients with neoplastic diseases |
| Q47753506 | Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM. |
| Q38096877 | Inflammatory markers in patients after hematopoietic stem cell transplantation |
| Q33781213 | Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation |
| Q44614034 | Intestinal response to myeloablative chemotherapy in piglets |
| Q40094805 | Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis |
| Q36004850 | Low serum citrulline concentration correlates with catheter-related bloodstream infections in children with intestinal failure |
| Q37503363 | Management of bacteremia in patients undergoing hematopoietic stem cell transplantation |
| Q34678894 | Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. |
| Q38246766 | Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis |
| Q37810071 | Mucositis in malignant hematology |
| Q40214682 | Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients. |
| Q40266258 | Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. |
| Q48094065 | Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase. |
| Q33557148 | Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. |
| Q27027650 | Oral complications in hematopoietic stem cell recipients: the role of inflammation |
| Q42280166 | Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study |
| Q40333673 | Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation |
| Q59413236 | Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution |
| Q92921192 | The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy |
| Q44340753 | Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. |
Search more.